| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.3 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |